• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于监测肺癌化疗疗效及相关肾损伤的尿液生物正交报告分子。

Urinary bioorthogonal reporters for the monitoring of the efficacy of chemotherapy for lung cancer and of associated kidney injury.

作者信息

Cheng Penghui, Zeng Ziling, Liu Jing, Liew Si Si, Hu Yuxuan, Xu Mengke, Pu Kanyi

机构信息

School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University, Singapore, Singapore.

Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.

出版信息

Nat Biomed Eng. 2025 May;9(5):686-699. doi: 10.1038/s41551-024-01340-1. Epub 2025 Jan 29.

DOI:10.1038/s41551-024-01340-1
PMID:39880894
Abstract

The utility of urinary tests for the monitoring of the treatment efficacy and adverse events of anticancer therapies is constrained by the low concentration of relevant urinary biomarkers. Here we report, using mice with lung cancer and treated with chemotherapy, of a urinary fluorescence test for the concurrent monitoring of the levels of a tumour biomarker (cathepsin B) and of a biomarker of chemotherapy-induced kidney injury (N-acetyl-β-D-glucosaminidase). The test involves two intratracheally administered urinary reporters leveraging caged bioorthogonal click handles for the biomarker-dependent activation of 'clickability' and renal clearance, and the bioorthogonal click reaction of each renally cleared reporter with paired fluorescence indicators in the collected urine. In mouse models of chemotherapy-treated orthotopic lung cancer and of cisplatin-induced kidney injury, lower urinary fluorescence signals (which can be measured by a smartphone camera) for tumour and kidney injury levels positively correlated with animal weight gain and survival time. Biomarker-activated bioorthogonal click reactivity and renal clearance combined with bioorthogonally triggered fluorescence in vitro may enable specific, sensitive and rapid urinary assays for the monitoring of other physiopathological processes.

摘要

尿液检测在监测抗癌治疗的疗效和不良事件方面的效用受到相关尿液生物标志物浓度较低的限制。在此,我们报告了一种针对肺癌小鼠并接受化疗的尿液荧光检测方法,用于同时监测肿瘤生物标志物(组织蛋白酶B)和化疗诱导的肾损伤生物标志物(N - 乙酰 - β - D - 氨基葡萄糖苷酶)的水平。该检测涉及两种经气管内给药的尿液报告分子,利用笼形生物正交点击手柄实现生物标志物依赖性的“可点击性”激活和肾脏清除,以及每个经肾脏清除的报告分子与收集尿液中配对荧光指示剂的生物正交点击反应。在化疗治疗的原位肺癌和顺铂诱导的肾损伤小鼠模型中,肿瘤和肾损伤水平的较低尿液荧光信号(可通过智能手机摄像头测量)与动物体重增加和生存时间呈正相关。生物标志物激活的生物正交点击反应性和肾脏清除与体外生物正交触发的荧光相结合,可能实现用于监测其他生理病理过程的特异性、灵敏且快速的尿液检测。

相似文献

1
Urinary bioorthogonal reporters for the monitoring of the efficacy of chemotherapy for lung cancer and of associated kidney injury.用于监测肺癌化疗疗效及相关肾损伤的尿液生物正交报告分子。
Nat Biomed Eng. 2025 May;9(5):686-699. doi: 10.1038/s41551-024-01340-1. Epub 2025 Jan 29.
2
Urinary kidney injury molecule-1 and monocyte chemotactic protein-1 are noninvasive biomarkers of cisplatin-induced nephrotoxicity in lung cancer patients.尿肾损伤分子-1和单核细胞趋化蛋白-1是肺癌患者顺铂诱导肾毒性的非侵入性生物标志物。
Cancer Chemother Pharmacol. 2015 Nov;76(5):989-96. doi: 10.1007/s00280-015-2880-y. Epub 2015 Sep 25.
3
Early measurement of urinary N-acetyl-β-glucosaminidase helps predict severe hyponatremia associated with cisplatin-containing chemotherapy.早期测定尿N-乙酰-β-葡萄糖苷酶有助于预测含顺铂化疗相关的严重低钠血症。
J Infect Chemother. 2015 Jul;21(7):502-6. doi: 10.1016/j.jiac.2015.03.008. Epub 2015 Mar 20.
4
Correlation of prechemotherapy urinary megalin ectodomain (A-megalin) levels with the development of cisplatin-induced nephrotoxicity: a prospective observational study.化疗前尿 megalin 外显子(A-megalin)水平与顺铂诱导肾毒性发展的相关性:一项前瞻性观察研究。
BMC Cancer. 2019 Dec 2;19(1):1170. doi: 10.1186/s12885-019-6398-2.
5
Urinary aminopeptidase activities as early and predictive biomarkers of renal dysfunction in cisplatin-treated rats.尿氨肽酶活性作为顺铂治疗大鼠肾功能障碍的早期和预测性生物标志物。
PLoS One. 2012;7(7):e40402. doi: 10.1371/journal.pone.0040402. Epub 2012 Jul 5.
6
Urinary protein biomarkers of kidney injury in patients receiving cisplatin chemotherapy.顺铂化疗患者肾损伤的尿蛋白生物标志物。
Exp Biol Med (Maywood). 2018 Feb;243(3):272-282. doi: 10.1177/1535370217745302. Epub 2017 Dec 12.
7
Identification of urinary candidate biomarkers of cisplatin-induced nephrotoxicity in patients with carcinoma.鉴定癌症患者顺铂诱导肾毒性的尿液候选生物标志物。
J Proteomics. 2020 Jan 6;210:103533. doi: 10.1016/j.jprot.2019.103533. Epub 2019 Oct 17.
8
Urinary vanin-1 as a novel biomarker for early detection of drug-induced acute kidney injury.尿 Vanin-1 作为一种新型生物标志物用于早期检测药物诱导的急性肾损伤。
J Pharmacol Exp Ther. 2012 Jun;341(3):656-62. doi: 10.1124/jpet.112.192807. Epub 2012 Mar 7.
9
Evaluation of urinary vanin-1 for the early prediction of cisplatin-induced acute kidney injury during neoadjuvant chemotherapy for esophageal cancer.尿香草扁桃酸-1在食管癌新辅助化疗期间对顺铂诱导的急性肾损伤早期预测中的评估
Cancer Chemother Pharmacol. 2024 Dec 23;95(1):11. doi: 10.1007/s00280-024-04737-6.
10
Profiling of Kidney Injury Biomarkers in Patients Receiving Cisplatin: Time-dependent Changes in the Absence of Clinical Nephrotoxicity.接受顺铂治疗患者的肾损伤生物标志物分析:无临床肾毒性情况下的时间依赖性变化
Clin Pharmacol Ther. 2017 Apr;101(4):510-518. doi: 10.1002/cpt.606. Epub 2017 Feb 14.

本文引用的文献

1
Urine biomarkers in bladder cancer - current status and future perspectives.膀胱癌中的尿液生物标志物——现状与未来展望
Nat Rev Urol. 2023 Oct;20(10):597-614. doi: 10.1038/s41585-023-00773-8. Epub 2023 May 24.
2
Mitigating acute chemotherapy-associated adverse events in patients with cancer.减轻癌症患者化疗相关急性不良事件。
Nat Rev Clin Oncol. 2022 Nov;19(11):681-697. doi: 10.1038/s41571-022-00685-3. Epub 2022 Oct 11.
3
Harnessing big data to characterize immune-related adverse events.利用大数据来描述免疫相关不良事件。
Nat Rev Clin Oncol. 2022 Apr;19(4):269-280. doi: 10.1038/s41571-021-00597-8. Epub 2022 Jan 17.
4
Bioorthogonal chemistry.生物正交化学
Nat Rev Methods Primers. 2021;1. doi: 10.1038/s43586-021-00028-z. Epub 2021 Apr 15.
5
Current and Future Development in Lung Cancer Diagnosis.肺癌诊断的现状与未来发展。
Int J Mol Sci. 2021 Aug 12;22(16):8661. doi: 10.3390/ijms22168661.
6
Urinary biomarkers to mitigate diagnostic delay in bladder cancer during the COVID-19 era.用于减轻 COVID-19 时代膀胱癌诊断延误的尿液生物标志物。
Nat Rev Urol. 2021 Apr;18(4):185-187. doi: 10.1038/s41585-020-00419-z.
7
Multiplex Optical Urinalysis for Early Detection of Drug-Induced Kidney Injury.多重光学尿液分析用于早期发现药物性肾损伤。
Anal Chem. 2020 Apr 21;92(8):6166-6172. doi: 10.1021/acs.analchem.0c00989. Epub 2020 Apr 10.
8
Tailoring Kidney Transport of Organic Dyes with Low-Molecular-Weight PEGylation.用低分子量聚乙二醇化定制有机染料的肾脏转运
Bioconjug Chem. 2020 Feb 19;31(2):241-247. doi: 10.1021/acs.bioconjchem.9b00707. Epub 2019 Nov 23.
9
Carcinoembryonic antigen and CYFRA 21-1 responses as prognostic factors in advanced non-small cell lung cancer.癌胚抗原和细胞角蛋白19片段作为晚期非小细胞肺癌预后因素的研究
Transl Lung Cancer Res. 2019 Jun;8(3):227-234. doi: 10.21037/tlcr.2019.06.08.
10
Molecular optical imaging probes for early diagnosis of drug-induced acute kidney injury.用于药物诱导的急性肾损伤早期诊断的分子光学成像探针。
Nat Mater. 2019 Oct;18(10):1133-1143. doi: 10.1038/s41563-019-0378-4. Epub 2019 May 27.